EP3177321
TUMOR ANTIGEN SPECIFIC ANTIBODIES AND TLR3 STIMULATION TO ENHANCE THE PERFORMANCE OF CHECKPOINT INTERFERENCE THERAPY OF CANCER
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
7.8.2015EP published:
25.11.2020EP application number:
15829910.7
EPO information:
European Patent Register
Max expiry date:
6.8.2035
Title:
TUMOR ANTIGEN SPECIFIC ANTIBODIES AND TLR3 STIMULATION TO ENHANCE THE PERFORMANCE OF CHECKPOINT INTERFERENCE THERAPY OF CANCER
Timeline
Today
7.8.2015EP application
25.11.2020EP Publication
Owner
Name:
Oncoquest Pharmaceuticals Inc.Address:
670-21 Sannae-ro, Sannae-myeon, Miryang-Si, KR
Inventor
Name:
MADIYALAKAN, RagupathyAddress:
Edmonton, Alberta T6E 2S1, CA
Name:
NICODEMUS, Christopher F.Address:
Charlestown, Massachusetts 02129, US
Priority
Number:
201462034915 PDate:
8.8.2014Country:
US
Classification
Categories:
A61K 39/395, A61K 39/39, A61P 35/00, A61P 37/02